Mateon Therapeutics

Share on: 

Mateon Therapeutics is developing OXi4503 for the treatment of acute myeloid leukemia. OXi4503 has a unique dual mechanism of action which causes the release of leukemic stem cells from the bone marrow and enables their destruction.

The company is also using artificial intelligence to develop treatments for coronavirus.

Career Page(s): 
South San Francisco CA
United States